MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-20-2026
Vivos Therapeutics Total Assets 2011-2026 | VVOS
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Vivos Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25.2 M | 15.3 M | 10.7 M | 13.7 M | 33.7 M | 25.3 M | 7.55 M | 8.2 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 33.7 M | 7.55 M | 17.5 M |
Quarterly Total Assets Vivos Therapeutics
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25 M | 25.6 M | 26 M | 11.3 M | 15.3 M | 15.3 M | 15.8 M | 11.8 M | 10.7 M | 10.3 M | 13.7 M | - | 13.7 M | 18.4 M | 24.4 M | 29.6 M | 33.7 M | 41 M | 33.7 M | 22 M | 25.3 M | 25.3 M | 25.3 M | 25.3 M | 7.55 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 41 M | 7.55 M | 21.1 M |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
EDAP TMS S.A.
EDAP
|
86.1 M | $ 4.38 | 4.29 % | $ 164 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B |  USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
720 M | - | - | $ 3.31 B | USA |
 |
Eargo
EAR
|
132 M | - | - | $ 10.2 M | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
97.7 M | $ 12.54 | 2.41 % | $ 355 M | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
791 M | $ 7.9 | 0.06 % | $ 1.19 B | USA |
 |
IRIDEX Corporation
IRIX
|
29.2 M | $ 1.01 | -1.46 % | $ 17.1 M | USA |
 |
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
188 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | USA |
 |
Helius Medical Technologies
HSDT
|
304 M | $ 1.91 | -6.62 % | $ 42.1 M | USA |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
LENSAR
LNSR
|
71.4 M | $ 5.79 | -3.5 % | $ 69.2 M | USA |
 |
Cytosorbents Corporation
CTSO
|
44.2 M | $ 0.5 | 0.83 % | $ 31.1 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
509 M | $ 17.32 | -2.75 % | $ 406 M | USA |
 |
Delcath Systems
DCTH
|
124 M | $ 10.97 | 0.18 % | $ 393 M | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
Pulmonx Corporation
LUNG
|
129 M | $ 1.65 | -2.08 % | $ 67.1 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
LivaNova PLC
LIVN
|
2.61 B | $ 73.67 | 0.86 % | $ 4.02 B |  Britain |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Myomo
MYO
|
38.6 M | $ 1.08 | - | $ 45.2 M | USA |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | USA |
 |
MiMedx Group
MDXG
|
343 M | $ 3.72 | 1.23 % | $ 550 M | USA |
 |
Electromed
ELMD
|
53.8 M | $ 38.44 | -1.71 % | $ 325 M | USA |
 |
Orthofix Medical
OFIX
|
851 M | $ 9.38 | -1.16 % | $ 371 M |  Curacao |
 |
Butterfly Network
BFLY
|
297 M | $ 4.41 | -4.45 % | $ 1.09 B | USA |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
Profound Medical Corp.
PROF
|
77.5 M | $ 6.85 | -0.8 % | $ 207 M | Canada |
 |
Second Sight Medical Products
EYES
|
39.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
8.25 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
5.3 B | $ 81.88 | -0.69 % | $ 11.1 B | USA |
 |
Sintx Technologies
SINT
|
9.51 M | $ 2.21 | -0.17 % | $ 6.13 M | USA |
 |
Insulet Corporation
PODD
|
3.19 B | $ 142.49 | -0.11 % | $ 10 B | USA |
 |
CONMED Corporation
CNMD
|
2.33 B | $ 35.85 | 0.93 % | $ 1.11 B | USA |
 |
Inspire Medical Systems
INSP
|
907 M | $ 42.31 | -1.76 % | $ 1.24 B | USA |
 |
Integer Holdings Corporation
ITGR
|
3.41 B | $ 90.28 | 0.26 % | $ 3.14 B | USA |
 |
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
13.7 B | $ 86.17 | 0.24 % | $ 50.4 B | USA |
 |
TransMedics Group
TMDX
|
1.07 B | $ 67.24 | -0.87 % | $ 2.29 B | USA |